What is Gameto?
Gameto is a pioneering women's health biotechnology company focused on developing novel therapeutic programs. Leveraging a sophisticated cell engineering platform, originally developed with George Church's lab at Harvard Medical School, Gameto aims to address critical unmet needs in women's health. The company was co-founded by Dr. Dina Radenkovic, a medical doctor with entrepreneurial experience, and Martin Varsavsky, a notable figure in the fertility sector and founder of Inception Prelude. This blend of scientific expertise and business acumen positions Gameto to make significant advancements in the field.
How much funding has Gameto raised?
Gameto has raised a total of $158M across 5 funding rounds:
Series A
$20M
Other Financing Round
$17M
Series B
$33M
Series C
$44M
Private Equity
$44M
Series A (2022): $20M with participation from Anne Wojcicki, Future Ventures, BOLD Capital Partners, Plum Alley, TA Ventures, Lux Capital, Overwater Ventures, and Robert Nelsen
Other Financing Round (2022): $17M led by Arcadia Investment Partners, Future Ventures, BOLD Capital Partners, Insight Partners, and Plum Alley
Series B (2024): $33M supported by RA Capital Management, Future Ventures, BOLD Capital Partners, Insight Partners, and Two Sigma Ventures
Series C (2025): $44M featuring Overwater Ventures, RA Capital Management, Insight Partners, BOLD Capital Partners, Two Sigma Ventures, and Arcadia Investment Group
Private Equity (2025): $44M, investors not publicly disclosed
Key Investors in Gameto
Overwater Ventures
Overwater Ventures partners with pre-seed and seed stage founders addressing significant global challenges, providing support in commercialization and helping technical founders transition from R&D to product launch and scaling.
RA Capital Management
RA Capital Management is a multi-stage investment manager focused on evidence-based investing in public and private healthcare and life science companies, including those developing drugs, medical devices, diagnostics, and research tools.
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth software and technology companies, providing capital and hands-on operational support to help businesses scale from early stage to IPO.
What's next for Gameto?
With its latest major strategic investment, Gameto is poised for accelerated growth and the expansion of its research and development initiatives. The substantial capital infusion, including the recent $44M, will likely fuel the progression of its pipeline programs and further solidify its position in the women's health biotechnology sector. Future endeavors may include clinical trials, strategic partnerships, and the scaling of its proprietary cell engineering technology to address a broader range of conditions. The company's consistent access to significant funding rounds, from Series A to Series C and beyond, signals strong investor confidence in its long-term vision and potential market impact.
See full Gameto company page
